Press Release | Wed Dec 19, 2012 2:32am EST

EMD Serono: Phase III Trial of L-BLP25 (Stimuvax) in Patients with Non-Small Cell Lung Cancer Did not Meet Primary Endpoint

* Reuters is not responsible for the content in this press release.